Fluconazole in the prevention of infection in neonates

Effect of fluconazole in the prevention of infection in neonates with birth weight under 1200 grams admitted to neonatal intensive care unite

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170215032587N4

Enrollment

120

Registered

2018-11-10

Start date

2015-10-22

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Candidiasis. Condition 2: Sepsis. Candidiasis Other sepsis

Interventions

Intervention 1: Control group: Routine care. Intervention 2: Intervention group: Fluconazole, IV, 3 mg/kg, twice a week until the first 6 weeks of life.

Eligibility

Sex/Gender

All

Age

1 Days to 28 Days

Inclusion criteria

Inclusion criteria: Neonates with birth weight under 1200 grams Admitted to neonatal intensive care unite

Exclusion criteria

Exclusion criteria: Major congenital anomalies

Design outcomes

Primary

Measure	Time frame
Sepsis. Timepoint: 6 weeks after intervention. Method of measurement: Clinical symptoms and blood culture.	—

Secondary

Measure	Time frame
Pneumothorax. Timepoint: 6 weeks after intervention. Method of measurement: Chest X-ray.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Aghaali

Ghoum University of Medical Sciences

maghaali@muq.ac.ir+98 25 3285 2720

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026